Randomized trial of artesunate and mefloquine in comparison with quinine sulfate to treat P. falciparum malaria pregnant women
- PMID: 11800303
Randomized trial of artesunate and mefloquine in comparison with quinine sulfate to treat P. falciparum malaria pregnant women
Abstract
To compare the effectiveness and safety of quinine sulfate and artesunate with mefloquine for treating second trimester pregnancy in women who suffered from Plasmodium falciparum malaria. The prospective study was done in Srisangwal Hospital, Mae Hong Son, Thailand. Sixty, second to third trimester pregnant patients with P. falciparum infection, were recruited at random. They received either quinine sulfate 10 mg/kg/day for at least 7 days, 29 women (group I), or oral artesunate 2 mg/kg as the first dose, 1 mg/kg every 12 hours orally for at least 5 days together with split doses of mefloquine, 15 mg/kg and 6 hours later 10 mg/kg orally 1 day after artesunate was stopped, 28 women (group II). Three cases (5%) were lost to follow-up before delivery, one case in group I and two cases in group II. After treatment, the mean hematocrit of group I was significantly less than group II (p = 0.000). The PCT (parasite clearance time) and FCT (fever clearance time) of group II were significantly shorter than group I (p = 0.000). None of the patients in both groups had recrudescences within 28 days. Group I had more adverse effects than group II. No adverse neurological effects in pregnancy were found in both groups. The calcification of placenta and IUGR (Intrauterine growth retard) were not different between the two groups (p = 0.964, 0.363 respectively). The PCT was not different between the calcified placenta group and normal placenta group (p = 0.058), but the TTPP (Total time of parasite presentation) was (p = 0.000). TTPP related to low birth weight and low apgar score at 1 minute might be the cause (p = 0.000, 0.000 F = 5.261, 21.627 respectively). TTPP and PCT related to neonatal blood pH and caused low neonatal blood pH (p = 0.000, 0.001 F = 24.351, 11.162 respectively). The physical and neurological development of the babies at 2, 4, 6 and 12 months follow-up, were normal and there were no congenital abnormalities in either group. TTPP relating to fetal outcome, the longer the TTPP, the worse the fetal outcome, so we should diagnose early and treat P. falciparum malaria in pregnancy to prevent fetal jeopardy. Artesunate with mefloquine could shorten the PCT more than quinine sulfate in pregnancy, so the fetal outcome was better than that of quinine sulfate. In cases of prolonged infection before treatment, artesunate might be the alternative treatment of P. falciparum malaria in pregnancy. However, its safety should be carefully studied further with a larger sample size.
Similar articles
-
Comparison of oral artesunate and quinine plus tetracycline in acute uncomplicated falciparum malaria.Bull World Health Organ. 1994;72(2):233-8. Bull World Health Organ. 1994. PMID: 8205643 Free PMC article. Clinical Trial.
-
Pharmacokinetics of mefloquine alone or in combination with artesunate.Bull World Health Organ. 1994;72(1):83-7. Bull World Health Organ. 1994. PMID: 8131255 Free PMC article. Clinical Trial.
-
An open, randomized trial of three-day treatment with artesunate combined with a standard dose of mefloquine divided over either two or three days, for acute, uncomplicated falciparum malaria.Southeast Asian J Trop Med Public Health. 2005 May;36(3):591-6. Southeast Asian J Trop Med Public Health. 2005. PMID: 16124422 Clinical Trial.
-
Quinine toxicity when given with doxycycline and mefloquine.Southeast Asian J Trop Med Public Health. 1994 Jun;25(2):397-400. Southeast Asian J Trop Med Public Health. 1994. PMID: 7855666 Review.
-
Research on new antimalarial drugs and the use of drugs in combination at the Bangkok Hospital for Tropical Diseases.Southeast Asian J Trop Med Public Health. 1998 Jun;29(2):344-54. Southeast Asian J Trop Med Public Health. 1998. PMID: 9886126 Review.
Cited by
-
Intermittent preventive treatment for malaria in pregnancy in Africa: what's new, what's needed?Malar J. 2007 Feb 16;6:16. doi: 10.1186/1475-2875-6-16. Malar J. 2007. PMID: 17306014 Free PMC article. Review.
-
Artesunate versus quinine for treating severe malaria.Cochrane Database Syst Rev. 2012 Jun 13;2012(6):CD005967. doi: 10.1002/14651858.CD005967.pub4. Cochrane Database Syst Rev. 2012. PMID: 22696354 Free PMC article.
-
Mefloquine safety and tolerability in pregnancy: a systematic literature review.Malar J. 2014 Feb 28;13:75. doi: 10.1186/1475-2875-13-75. Malar J. 2014. PMID: 24581338 Free PMC article.
-
Treatment of uncomplicated and severe malaria during pregnancy.Lancet Infect Dis. 2018 Apr;18(4):e133-e146. doi: 10.1016/S1473-3099(18)30065-3. Epub 2018 Jan 31. Lancet Infect Dis. 2018. PMID: 29395998 Free PMC article. Review.
-
Malaria in pregnancy: the difficulties in measuring birthweight.BJOG. 2011 May;118(6):671-8. doi: 10.1111/j.1471-0528.2010.02880.x. Epub 2011 Feb 18. BJOG. 2011. PMID: 21332632 Free PMC article. Review.